FMC (NYSE:FMC) Bolsa

FMC CORP

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

What Wedbush’s Dan Ives Said

Equities

News

Markets

DASH

ISRG

PLTR

Palantir se une al S&amp;P 100 tras subir un 60% y consolidarse como líder en la IA. ¿Seguirá su ascenso o enfrentará correcciones?

Palantir (PLTR) al S&amp;P 100 y subiendo: proyección de los analistas sobre su precio futuro

FMC Corp

FRMRS&MER BNCORP LODI CA by Farmers & Merchants Bancorp

Farmers & Merchants Bancorp

Federal Home Loan Mortgage Corp

Northern Lights Fund Trust IV FM Compounders Equity ETF

FRESENIUS MED CARE AG ORD by Fresenius Medical Care AG

Fresenius Medical Care AG

FM Focus Equity ETF

FORAN MINING CORP by Foran Mining Corporation

Foran Mining Corp

General

FMC Corporation Partners With Corteva Agriscience To Expand FMC's Fluindapyr Fungicide Technology In The U.S. Corn And Soybean Markets

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 8.55%</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Overweight rating and slashed the price target from $22 to $20 on May 5, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Wells Fargo analyst Michael Sison downgraded the stock from Overweight to Equal-Weight and lowered the price target from $17 to $13 on May 5, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On May 28, Huntsman announced that it has completed the strategic review of its European Maleic Anhydride business.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528">latest HUN news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528"><img loading="lazy" decoding="async" width="906" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353.png" alt="" class="wp-image-929655" style="width:634px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070822/image-353-768x710.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure>
<h3 class="wp-block-heading">FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 5.95%</li>
<li>Keybanc analyst Aleksey Yefremov maintained an Overweight rating and raised the price target from $49 to $53 on May 2, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Seaport Global analyst Michael Harrison maintained a Buy rating and cut the price target from $72 to $55 on March 5, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On April 30, FMC issued second-quarter adjusted EPS guidance below estimates.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest FMC <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528"><img loading="lazy" decoding="async" width="920" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354.png" alt="" class="wp-image-929656" style="width:604px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354.png 920w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070859/image-354-768x707.png 768w" sizes="(max-width: 920px) 100vw, 920px" /></a></figure>
<h3 class="wp-block-heading">The Chemours Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CC#NYSE">CC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 3.30%</li>
<li>Morgan Stanley analyst Vincent Andrews maintained an Equal-Weight rating and cut the price target from $22 to $15 on May 12, 2025. This analyst has an accuracy rate of 78%.</li>
<li>Mizuho analyst John Roberts upgraded the stock from Neutral to Outperform with a price target of $19 on March 27, 2025. This analyst has an accuracy rate of 73%.</li>
<li>Recent News: On May 6, Chemours reported worse-than-expected first-quarter adjusted EPS results.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528">latest CC news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0528"><img loading="lazy" decoding="async" width="908" height="815" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355.png" alt="" class="wp-image-929658" style="width:580px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/28070926/image-355-768x689.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45616471/jim-cramer-says-rocket-is-a-very-fine-company-recommends-buying-this-health-care-stock">Jim Cramer Says Rocket Is A &#8216;Very Fine&#8217; Company, Recommends Buying This Health Care Stock</a> </li>
</ul>
Photo via Shutterstock

Dividends

Price Target

Pre-Market Outlook

Analyst Ratings

Trading Ideas

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector.
<h3 class="wp-block-heading">Tronox Holdings plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TROX#NYSE">TROX</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 9.77%</li>
<li>BMO Capital analyst John McNulty downgraded the stock from Outperform to Market Perform and cut the price target from $13 to $7 on May 7, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Morgan Stanley analyst Vincent Andrews maintained an Equal-Weight rating and slashed the price target from $12 to $8 on May 5, 2024. This analyst has an accuracy rate of 79%.</li>
<li>Recent News: On April 30, Tronox Holdings posted first-quarter adjusted loss of 15 cents per share.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest TROX <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509"><img loading="lazy" decoding="async" width="908" height="815" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100.png" alt="" class="wp-image-909780" style="width:628px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09050938/image-100-768x689.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
<h3 class="wp-block-heading">Huntsman Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUN#NYSE">HUN</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 8.32%</li>
<li>JP Morgan analyst Jeffrey Zekauskas maintained an Overweight rating and cut the price target from $22 to $20 on May 5, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Wells Fargo analyst Michael Sison downgraded the stock from Overweight to Equal-Weight and slashed the price target from $17 to $13 on May 5, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Recent News: On May 1, Huntsman reported in-line loss for the first quarter.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest HUN <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509"><img loading="lazy" decoding="async" width="911" height="823" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101.png" alt="" class="wp-image-909782" style="width:559px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101.png 911w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051009/image-101-768x694.png 768w" sizes="(max-width: 911px) 100vw, 911px" /></a></figure>
<h3 class="wp-block-heading">FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.34%</li>
<li>Keybanc analyst Aleksey Yefremov maintained an Overweight rating and raised the price target from $49 to $53 on May 2, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Seaport Global analyst Michael Harrison maintained a Buy rating and cut the price target from $72 to $55 on March 5, 2025. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On April 30, FMC issued second-quarter adjusted EPS guidance below estimates.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest FMC <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0509"><img loading="lazy" decoding="async" width="912" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102.png" alt="" class="wp-image-909783" style="width:560px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/09051041/image-102-768x701.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/05/45285413/top-3-financial-stocks-which-could-rescue-your-portfolio-this-month">Top 3 Financial Stocks Which Could Rescue Your Portfolio This Month</a> </li>
</ul>
Photo via Shutterstock

TROX

Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks With Over 6% Dividend Yields

Keybanc analyst Aleksey Yefremov maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Overweight and raises the price target from $49 to $53.

Keybanc Maintains Overweight on FMC, Raises Price Target to $53

Throughout the last three months, 12 analysts have evaluated FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), offering a diverse set of opinions from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $47.08, a high estimate of $55.00, and a low estimate of $38.00. This current average represents a 21.65% decrease from the previous average price target of $60.09. 
<img src="https://www.benzinga.com/files/images/story/2025/1746133212_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of FMC's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$41.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Richard Garchitorena</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$41.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$49.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$51.00</td>
<td>-</td>
</tr>
<tr>
<td>Michael Harrison</td>
<td>Seaport Global</td>
<td>Lowers</td>
<td>Buy</td>
<td>$55.00</td>
<td>$72.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$51.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Benjamin Theurer</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$48.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$38.00</td>
<td>$66.00</td>
</tr>
<tr>
<td>Steve Byrne</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$48.00</td>
<td>$61.00</td>
</tr>
<tr>
<td>Joel Jackson</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$50.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Vincent Andrews</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$46.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$47.00</td>
<td>$78.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to FMC. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of FMC's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of FMC's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on FMC analyst ratings.</a>
<h2>About FMC</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>FMC's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: FMC's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 6.82%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: FMC's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.37% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): FMC's ROE excels beyond industry benchmarks, reaching -0.37%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): FMC's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.14% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 0.78, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying FMC: Insights From 12 Analyst Reviews

WIIM

FMC shares are trading lower after the company issued Q2 adjusted EPS guidance below estimates.

UBS analyst Joshua Spector maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Neutral and raises the price target from $38 to $41.

UBS Maintains Neutral on FMC, Raises Price Target to $41

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) affirms FY2025 Adj EPS guidance from $3.26-$3.70 to $3.26-$3.70 vs $3.41 analyst estimate. Affirms FY2025 sales outlook from $4.15 billion-$4.35 billion to $4.15 billion-$4.35 billion vs $4.19 billion estimate.

Guidance

FMC Affirms FY2025 Adj EPS Guidance of $3.26-$3.70 vs $3.41 Est; Affirms FY2025 Sales Guidance of $4.15B-$4.35B vs $4.19B Est

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) is looking for Q2 Adj EPS of $0.52-$0.68 vs $0.75 analyst estimate. sees sales of $940.000 million-$1.100 billion vs $1.03 billion analyst estimate.

FMC Sees Q2 Adj EPS $0.52-$0.68 vs $0.75 Est; Sees Sales $940.000M-$1.100B vs $1.03B Est

FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.09 by 100 percent. This is a 50 percent decrease over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $791.40 million which beat the analyst consensus estimate of $784.05 million by 0.94 percent. This is a 13.79 percent decrease over sales of $918.00 million the same period last year.

Earnings

Earnings Beats

FMC Q1 Adj. EPS $0.18 Beats $0.09 Estimate, Sales $791.40M Beat $784.05M Estimate

AEIS

ALGN

ALKT

AMCR

ANSS

ARAY

ATNI

AWRE

BLCO

BLFY

BLKB

BXMT

CACC

CAKE

CDNA

CFLT

CGNX

CHEF

CHRW

CLMB

CMPR

CNMD

CNXN

COCO

COKE

CPSH

CSLR

CSTM

CTOS

CTSH

CVEO

CWAN

CWEN

DFIN

EBAY

ENVX

EQIX

EQNR

ETSY

EXTR

FCPT

FFWM

FINW

FMBH

FORM

FTAI

GEHC

GKOS

GNRC

GRBK

GRMN

GTES

Earnings Scheduled For April 30, 2025

Wells Fargo analyst Richard Garchitorena maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Equal-Weight and lowers the price target from $43 to $41.

Wells Fargo Maintains Equal-Weight on FMC, Lowers Price Target to $41

Peru approves Keenali&#x2122; herbicide, transforming rice weed management in high-growth Latin American market&nbsp;
FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), a leading global agricultural sciences company, today announced it has received regulatory approval for Keenali&#x2122; herbicide powered by Dodhylex&#x2122; active (tetflupyrolimet) in Peru. The approval represents the first active ingredient and commercial product registration globally for this breakthrough herbicide technology. Dodhylex&#x2122; active is the first and only herbicide classified by the Herbicide Resistance Action Committee (HRAC) and the Weed Science Society of America (WSSA) as a Group 28 herbicide.

FMC Gets Regulatory Approval For Keenali Herbicide Powered By Dodhylex Active In Peru

In the preceding three months, 12 analysts have released ratings for FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), presenting a wide array of perspectives from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for FMC, revealing an average target of $50.75, a high estimate of $65.00, and a low estimate of $38.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 20.25%. 
<img src="https://www.benzinga.com/files/images/story/2025/1744668042_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The perception of FMC by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Aleksey Yefremov &#x7C;Keybanc &#x7C;Lowers &#x7C;Overweight &#x7C; $49.00&#x7C;$51.00 &#x7C; 
&#x7C;Duffy Fischer &#x7C;Goldman Sachs &#x7C;Announces &#x7C;Buy &#x7C; $51.00&#x7C;- &#x7C; 
&#x7C;Michael Harrison &#x7C;Seaport Global &#x7C;Lowers &#x7C;Buy &#x7C; $55.00&#x7C;$72.00 &#x7C; 
&#x7C;Aleksey Yefremov &#x7C;Keybanc &#x7C;Lowers &#x7C;Overweight &#x7C; $51.00&#x7C;$55.00 &#x7C; 
&#x7C;Benjamin Theurer &#x7C;Barclays &#x7C;Lowers &#x7C;Overweight &#x7C; $48.00&#x7C;$65.00 &#x7C; 
&#x7C;Joshua Spector &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $38.00&#x7C;$66.00 &#x7C; 
&#x7C;Steve Byrne &#x7C;B of A Securities &#x7C;Lowers &#x7C;Underperform &#x7C; $48.00&#x7C;$61.00 &#x7C; 
&#x7C;Joel Jackson &#x7C;BMO Capital &#x7C;Lowers &#x7C;Market Perform &#x7C; $50.00&#x7C;$62.00 &#x7C; 
&#x7C;Vincent Andrews &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $46.00&#x7C;$70.00 &#x7C; 
&#x7C;Arun Viswanathan &#x7C;RBC Capital &#x7C;Lowers &#x7C;Sector Perform &#x7C; $47.00&#x7C;$78.00 &#x7C; 
&#x7C;Patrick Cunningham &#x7C;Citigroup &#x7C;Raises &#x7C;Neutral &#x7C; $61.00&#x7C;$55.00 &#x7C; 
&#x7C;Benjamin Theurer &#x7C;Barclays &#x7C;Maintains &#x7C;Overweight &#x7C; $65.00&#x7C;$65.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to FMC. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of FMC compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of FMC's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
For valuable insights into FMC's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FMC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on FMC analyst ratings.</a>
<h2>Delving into FMC's Background</h2>
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
<h3>FMC's Economic Impact: An Analysis</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: FMC's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 6.82%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Materials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of -1.37%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): FMC's ROE stands out, surpassing industry averages. With an impressive ROE of -0.37%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): FMC's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.14% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a high debt-to-equity ratio of 0.78, FMC faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

12 Analysts Have This To Say About FMC

Keybanc analyst Aleksey Yefremov maintains FMC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Overweight and lowers the price target from $51 to $49.

Keybanc Maintains Overweight on FMC, Lowers Price Target to $49

FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>), a leading agricultural sciences company, today announced it has received registration in Brazil for&nbsp;Sofero&#x2122; Fall pheromone targeting fall armyworm (Spodoptera frugiperda). Sofero&#x2122; Fall is the first in the company's lineup of distinctive pheromone products for row crops offering growers a novel approach to sustainably control pests, manage resistance and boost productivity.
"The registration of&nbsp;Sofero&#x2122; Fall in Brazil marks a significant milestone in our efforts to bring high-performance, sustainable crop protection solutions to growers," said Ronaldo Pereira, FMC president. "We are excited to provide growers with a powerful new tool in the battle against fall armyworm. Fall armyworm has developed resistance to many traditional insecticides, and growers are seeking alternative solutions to complement their existing practices. Sofero&#x2122; Fall offers an efficient and sustainable way to overcome mounting resistance challenges and enhance the performance of their pest management programs."
Sofero&#x2122; Fall features an innovative mode of action based on mating disruption. This breakthrough technology harnesses the powerful signals of pheromones to naturally disrupt the mating cycles of fall armyworm, preventing it from reproducing. By breaking the pest cycle before the next generation can emerge, Sofero&#x2122; Fall protects crops in the early stages of development, reducing damage and supporting healthy growth. The unique, sprayable formulation leverages FMC's proprietary microencapsulation technology to improve stability and extend its effectiveness, optimizing performance and providing growers with longer-lasting protection.
Sofero&#x2122; Fall is the first product to launch under FMC's global Sofero&#x2122; pheromone solutions brand. The Sofero&#x2122; portfolio of products will target destructive pests in key crops including rice, corn, cotton and soybeans. Sofero&#x2122; pheromone solutions are designed to be used as part of an integrated program, combined with synthetics, biologicals and precision technologies to improve operational efficiency.
"Sofero&#x2122; pheromone solutions inspire a new way to think about crop protection – one that is focused on prevention over treatment," continued Pereira. "With our extensive portfolio and global reach, FMC is uniquely positioned to bring these game-changing solutions to growers around the world, creating a more sustainable future for agriculture while solving real problems in the field."
Registration for Sofero&#x2122; Frugi pheromone, which also targets fall armyworm, is pending in Mexico and anticipated in 2027.

FMC Corporation Receives First Product Registration In Brazil For Its Sofero Fall Pheromone

AXTA

Shares of companies in the broader chemicals sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

Biotech

FMC And Bayer Collaborate To Bring Isoflex Active Herbicide Technology To European Markets

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer recommended buying Shopify Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>).
As per recent news, Splitit announced the launch of its new, fully embedded Shopify App, Splitit Card Installments, on Tuesday<a href="https://www.benzinga.com/quote/SHOP">.</a>
Cramer said Plains All American Pipeline, L.P. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) is a &#8220;terrific&#8221; stock.
Morgan Stanley analyst Robert Kad raised the price target on the stock from $19 to $23 on Tuesday, supporting his view.
Cramer recommended selling SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>). &#8220;I regard SoundHound as a complete meme stock,&#8221; he added.
On Tuesday, SoundHound AI named Shawnna DelHierro as Senior Vice President and Chief Information Officer.
The Mad Money host recommended avoiding FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>).
On the earnings front, FMC Corporation is scheduled to release its first quarter 2025 earnings on Wednesday, April 30, 2025, after the closing bell.
When asked about Core Natural Resources, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNR#NYSE">CNR</a>), &#8220;There's just not much to these stocks. I wish they could find a bottom, but they can't.&#8221;
According to the recent earnings report, Core Natural Resources reported quarterly earnings of $1.04 per share on Feb. 20, which missed the analyst consensus estimate of $3.09 per share. The company reported quarterly sales of $595.291 million, which beat the analyst consensus estimate of $553.850 million.
Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) is a &#8220;winner,&#8221; Cramer said.
On Tuesday, Everfox disclosed a strategic partnership with Palantir to enhance joint command and control capabilities.
Cramer said, &#8220;You can own Rocket (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>).&#8221;
On March 10, Rocket Companies agreed to acquire Redfin Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDFN#NASDAQ">RDFN</a>), a digital real estate platform, in an all-stock transaction valued at $12.50 per share, or approximately $1.75 billion in equity.
Price Action:
<ul>
<li>Shopify shares gained 0.5% to settle at $109.82 on Tuesday.</li>
<li>Plains All American Pipeline shares gained 0.1% to close at $20.18 during the session.</li>
<li>SoundHound shares fell 1.1% to settle at $10.20.</li>
<li>FMC shares fell 1.3% to close at $41.20.</li>
<li>Rocket Companies&#8217; shares fell 2.8% to close at $13.38  on Tuesday.</li>
<li>Core Natural Resources shares rose 2% to settle at $76.25 on Tuesday.</li>
<li>Palantir shares fell 0.3% to close at $96.50.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44471817/top-2-health-care-stocks-that-are-ticking-portfolio-bombs-3">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>
Photo: Shutterstock

Media

RDFN

SHOP

SOUN

Jim Cramer: Palantir Is A 'Winner,' Recommends Selling This Tech Stock

Goldman Sachs analyst Duffy Fischer initiated coverage on several major U.S. agriculture input <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color" rel="noreferrer noopener">stocks, citing several factors</a>.
The analyst writes that they believe the agricultural macro environment is still stabilizing after the peak caused by the Russia-Ukraine war.
Fischer says that while Spring 2025 looks better than expected (excluding FX) thanks to expected higher corn acreage and a short Fall application window, they anticipate a continued drift toward normalized levels later this year.
CTVA: The analyst initiated coverage on Corteva, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTVA#NYSE">CTVA</a>) with a Buy <a target="_blank" href="https://www.benzinga.com/quote/ctva/analyst-ratings" rel="noreferrer noopener">and price forecast of $71</a>.
The analyst highlights the company&#8217;s strong seed and crop protection business, which is poised to benefit from significant cost tailwinds in 2025.
The analyst notes that the business is more focused on R&amp;D compared to crop protection, which gives it substantial pricing power, enabling it to maintain strong pricing even during down-cycles.
FMC: Fischer initiated coverage on FMC Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMC#NYSE">FMC</a>) with a Buy rating <a target="_blank" href="https://www.benzinga.com/quote/fmc/analyst-ratings" rel="noreferrer noopener">and price forecast of $51</a>.
The analyst notes that the company is the only pure-play crop protection firm in the group.
The post-patent strategy for Rynaxypyr holds promise, and its R&amp;D pipeline is expected to yield dividend by 2027+, adds the analyst.
Additionally, the analyst notes the market is undervaluing the potential growth from new product launches in 2026/27 and beyond, as current consensus estimates are below FMC&#8217;s 2027 guidance targets.
MOS: The analyst started coverage on Mosaic Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>) with a Buy rating <a target="_blank" href="https://www.benzinga.com/quote/mos/analyst-ratings" rel="noreferrer noopener">and price forecast of $31</a>.
The analyst writes that the major reason for favoring the stock is that phosphate has the most favorable supply-demand outlook heading into 2025, with limited capacity growth and rising demand from farmers and LFP EV batteries.
If the company can avoid production disruptions, it can improve capacity utilization, boosting margins during a period of strong phosphate stripping margins, adds the analyst.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/contracts/25/03/44304280/baker-hughes-novalt-gas-turbines-to-power-data-centers-amid-growing-ai-demand" target="_blank" rel="noreferrer noopener">Baker Hughes&#8217; NovaLT Gas Turbines To Power Data Centers Amid Growing AI Demand</a></li>
</ul>
Photo via Shutterstock.

Analyst Color

Large Cap

Initiation

CTVA

Goldman Sachs Agri Stock Picks: Corteva's R&D Edge, FMC's Pipeline, And Mosaic's Phosphate Advantage Set Up Strong Growth

Legal

Press Releases

FMC Corporation Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights – FMC

Commodities

FMC Corporation secures first global registration for agricultural breakthrough, Dodhylex™ active

FMC ALERT: Bragar Eagel & Squire, P.C. is Investigating FMC Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

FMC Corporation names Sara Velazquez Ponessa as new general counsel

FMC Corporation announces election of Steven Merkt to Board of Directors

FMC Corporation Declares Quarterly Dividend

FMC Corporation delivers first quarter results at higher end of guidance range, reaffirms full-year outlook

FMC Corporation demonstrates climate-smart, business-forward approach to sustainability

Kuehn Law Encourages Investors of FMC Corporation to Contact Law Firm

FMC Corporation and Corteva Agriscience collaborate to provide fluindapyr fungicide technology to more U.S. growers

American Vanguard Corporation Common Stock ($0.10 Par Value)

American Vanguard

Bioceres Crop Solutions Corp. - Ordinary Shares

Bioceres Crop Solutions

CF Industries Holdings, Inc. Common Stock

CF Industries Holdings

Corteva

Enlightify

Brazil Potash

Intrepid Potash

Mosaic

N2OFF

Scotts Miracle-Gro Company (The) Common Stock

Scotts Miracle Gro

CVR Partners, LP Common Units representing Limited Partner Interests

CVR Partners

Keybanc

Wells Fargo

Goldman Sachs

Seaport Global

Comments

FMC

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL